Expert Pitch
Rutgers University-New Brunswick

Rutgers Scholar Available to Discuss Global Financial Crisis

15-Jun-2020 11:25 AM EDT, by Rutgers University-New Brunswick

Steven Adelkoff, a lecturer at Rutgers University’s School of Arts and Sciences, is available to discuss the COVID-19-driven global financial crisis, and lessons learned from past financial crises. Adelkoff teaches Global Governance of Financial Crises in the MA program in Political science - Concentration in United Nations & Global Policy Studies at Rutgers-New Brunswick.

“We can argue what’s happened in the past was a prelude to this global financial crisis,” said Adelkoff. “If it wasn’t the pandemic, it was going to be something else. Growth was slowing, interest rates had been historically low for nearly two decades and asset prices were inflated. There was an asset bubble, in real estate and the stock market. Things were beginning to overheat and slow down at the same time. If you look at the crises of the past, you can see similar signs.”

He also noted, “We’re now in a period of de-globalization, which began in earnest around 2015. People worldwide will be traveling less, and will become more internationally disconnected. We’re going to bring more means of production back to the U.S, most likely at higher cost. There will be lower growth which, combined with the unprecedented recent stimulus, will mean higher sovereign debt. Every government entity - internationally, nationally and locally - will be fighting for tax revenues. There will be limits. You’ll see it reflected in various ways: tariffs among nations; sovereigns failing to cooperate to corner tax evasion; states searching for revenues through increased taxes on our vices.”

Adelkoff is an expert in international business, business ethics and the global flow of money. For over two decades, both as a partner of the global law firm of K&L Gates and as an international entrepreneur, Adelkoff has worked in all aspects of the project finance, structured finance, alternative investment and capital markets industries. He has lead teams negotiating domestic and international transactions involving real estate, commodities, power generation, renewable energy, commodity exploration, investment management platforms, and investment funds representing a range of strategies.

For interviews, contact: Megan Schumann, megan.schumann@rutgers.edu, 848-445-1907

###

Broadcast interviews: Rutgers University–New Brunswick has broadcast-quality TV and radio studios available for remote live or taped interviews with Rutgers experts. For more information, contact Neal Buccino neal.buccino@echo.rutgers.edu

ABOUT RUTGERS—NEW BRUNSWICK

Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship university is a leading public research institution and a member of the prestigious Association of American Universities. It is home to internationally acclaimed faculty and has 12 degree-granting schools and a Division I Athletics program. It is the Big Ten Conference’s most diverse university. Through its community of teachers, scholars, artists, scientists, and healers, Rutgers is equipped as never before to transform lives.

 




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
1.0988